SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global tissue plasminogen activator market is estimated to be valued at US$ 2,455.4 million in 2020 and is expected to exhibit a ...

We showed that TPA, a serine protease known for its fibrinolytic activity, enhances NMDA-mediated calcium signaling and subsequent excitotoxic neuronal injury. This potentiation of excitotoxicity is ...

Clinical characteristics and outcome of cancer patients with tuberculosis. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.

LOS ANGELES — The cost of tissue plasminogen activator (tPA; alteplase, Genentech) has more than doubled over the past decade, but Medicare/Medicaid reimbursement has not kept pace, new research shows ...

Although beneficial within 4.5 hours of stroke onset, administering recombinant tissue plasminogen activator (tPA) beyond that window appears to increase the risk of dying, a pooled analysis of eight ...

To the Editor: Hemmelgarn et al. (Jan. 27 issue) 1 evaluated prophylactic recombinant tissue plasminogen activator (rt-PA) for preventing dialysis catheter malfunction. I have a few caveats regarding ...

Team finds closed plasminogen conformation transiently exposes binding site. Scientists report the X-ray crystal structure of full-length human plasminogen, and describe binding of blood clots to ...

CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...